TD Securities (USA)’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$2K Hold
32
0.02% 362
2015
Q4
$2K Sell
32
-50
-61% -$3.36K 0.02% 359
2015
Q3
$5K Sell
82
-58,090
-100% -$4.06M 0.05% 382
2015
Q2
$4.22M Buy
58,172
+6,330
+12% +$467K 0.06% 367
2015
Q1
$3.98M Sell
51,842
-3,042
-6% -$218K 0.06% 363
2014
Q4
$3.68M Buy
54,884
+4,369
+9% +$276K 0.05% 388
2014
Q3
$3.06M Buy
50,515
+6
+0% +$370 0.05% 402
2014
Q2
$2.96M Buy
50,509
+3,153
+7% +$185K 0.05% 424
2014
Q1
$2.74M Sell
47,356
-3,952
-8% -$212K 0.05% 413
2013
Q4
$2.75M Sell
51,308
-696
-1% -$41.3K 0.05% 423
2013
Q3
$3.21M Sell
52,004
-1,879
-3% -$112K 0.06% 364
2013
Q2
$3.27M Buy
+53,883
New +$3.21M 0.07% 347

Other funds holding DGX

TD Securities (USA)'s DGX Position: Q1 2016 in Review

TD Securities (USA) held its Quest Diagnostics (DGX) position steady in Q1 2016 at 32 shares worth $2K. The position accounts for 0.02% of the portfolio, ranked #362.

TD Securities (USA) first reported a position in DGX in Q2 2013 and has held it in 12 quarters since. The position peaked at $4.22M in Q2 2015. 557 funds tracked by Wall St. Rank hold DGX as of Q1 2016.

  • TD Securities (USA) held 32 shares of Quest Diagnostics worth $2K as of Q1 2016.
  • TD Securities (USA) left its Quest Diagnostics share count unchanged in Q1 2016.
  • Quest Diagnostics made up 0.02% of TD Securities (USA)'s portfolio in Q1 2016, its #362 holding.
  • TD Securities (USA) first reported a position in Quest Diagnostics in Q2 2013 and has held it in 12 quarters since.
  • TD Securities (USA)'s Quest Diagnostics position peaked at $4.22M in Q2 2015.
  • 557 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.